Publication | Closed Access

Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment

Breast OncologyTamoxifen TreatmentMedicinePathologyRelapse-free TimeMir-10a PredictBreast CancerMicrorna DetectionOncologyRadiation OncologyTumor MicroenvironmentEndocrine-related Cancer